申请人:FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
公开号:US20160237057A1
公开(公告)日:2016-08-18
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: It further discloses a pharmaceutical composition comprising the compounds of Formula (I) and their uses as anti-proliferative and pro-apoptotic agents for cancer therapy.
本发明涉及式(I)的化合物或其药学上可接受的盐或溶剂:它进一步揭示了包含式(I)化合物的制药组合物以及它们作为抗增殖和促凋亡剂用于癌症治疗的用途。